← FDA Drug Approvals (Drugs@FDA)
NAFCILLIN SODIUM
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: FRESENIUS · Approved 2019-12-10
Drug application
- FDA Application #
ANDA206682- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- NAFCILLIN SODIUM
- Generic name
- Nafcillin Sodium
- Active ingredients
- NAFCILLIN SODIUM
- Dosage form
- INJECTABLE
- Route
- INJECTION
- Marketing status
- Discontinued
- Sponsor
- FRESENIUS
- First approval
- 2019-12-10
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown